Serum levels of VCAM‐1 are associated with survival in patients treated with nivolumab for NSCLC

BACKGROUND: High circulating levels of cellular adhesion molecules (CAMs) in non‐small cell lung cancer (NSCLC) have been supposed to act as a negative prognostic factor. Here, we explored the predictive role of pre‐treatment levels of CAMs in previously treated patients receiving nivolumab for NSCL...

Descripción completa

Detalles Bibliográficos
Autores principales: Carbone, Federico, Ministrini, Stefano, Bonaventura, Aldo, Vecchié, Alessandra, Minetti, Silvia, Bardi, Nicholas, Elia, Edoardo, Ansaldo, Anna Maria, Ferrara, Daniele, Rijavec, Erika, Dal Bello, Maria Giovanna, Biello, Federico, Rossi, Giovanni, Tagliamento, Marco, Alama, Angela, Coco, Simona, Spallarossa, Paolo, Grossi, Francesco, Genova, Carlo, Montecucco, Fabrizio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9286788/
https://www.ncbi.nlm.nih.gov/pubmed/34390488
http://dx.doi.org/10.1111/eci.13668

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9286788/
https://www.ncbi.nlm.nih.gov/pubmed/34390488
http://dx.doi.org/10.1111/eci.13668

Ejemplares similares